106 related articles for article (PubMed ID: 6174138)
1. Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.
Begent RH; Chester KA; Walker LC; Tucker DF
Br J Cancer; 1982 Feb; 45(2):217-22. PubMed ID: 6174138
[TBL] [Abstract][Full Text] [Related]
2. Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasia.
Lahey SJ; Steele G; Rodrick ML; Berkowitz R; Goldstein DP; Ross DS; Ravikumar TS; Wilson RE; Byrn R; Thomas P
Cancer; 1984 Mar; 53(6):1316-21. PubMed ID: 6198067
[TBL] [Abstract][Full Text] [Related]
3. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complex levels in patients with gestational trophoblastic neoplasia.
Rayner AA; Berkowitz R; Steele G; Schur PH; Rodrick ML; Goldstein DP; Harte PJ; Wilson RE; Zamcheck N; Munroe AE
J Natl Cancer Inst; 1982 Jul; 69(1):23-6. PubMed ID: 6285061
[TBL] [Abstract][Full Text] [Related]
5. Circulating antibodies against human chorionic gonadotropin following trophoblastic disease.
de Bruijn HW; Groenhuis A; Aalders JG
Gynecol Oncol; 1984 Sep; 19(1):114-9. PubMed ID: 6088369
[TBL] [Abstract][Full Text] [Related]
6. Tumour-marker levels and prognosis in malignant teratoma of the testis.
Germa-Lluch JR; Begent RH; Bagshawe KD
Br J Cancer; 1980 Dec; 42(6):850-5. PubMed ID: 6161630
[TBL] [Abstract][Full Text] [Related]
7. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
8. The immune system in disease: gestational trophoblastic tumours.
Newlands ES; Fisher RA; Searle F
Baillieres Clin Obstet Gynaecol; 1992 Sep; 6(3):519-39. PubMed ID: 1332835
[TBL] [Abstract][Full Text] [Related]
9. Problems of interpretation of serum concentrations of alpha-foetoprotein (AFP) in patients receiving cytotoxic chemotherapy for malignant germ cell tumours.
Coppack S; Newlands ES; Dent J; Mitchell H; Goka G; Bagshawe KD
Br J Cancer; 1983 Sep; 48(3):335-40. PubMed ID: 6193801
[TBL] [Abstract][Full Text] [Related]
10. Specific binding proteins for human chorionic gonadotrophin in a patient with trophoblastic disease.
Chan DW; Bill MJ; Rosenshein N
Am J Clin Pathol; 1981 Aug; 76(2):214-6. PubMed ID: 6267931
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
Stevens MJ; Norman AR; Dearnaley DP; Horwich A
J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
[TBL] [Abstract][Full Text] [Related]
12. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
Vogelzang NJ; Lange PH; Goldman A; Vessela RH; Fraley EE; Kennedy BJ
Cancer Res; 1982 Nov; 42(11):4855-61. PubMed ID: 6181870
[TBL] [Abstract][Full Text] [Related]
13. Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
Nisselbaum JS; Bosl GJ; Golbey RB; Schwartz DC; Schwartz MK
Ann Clin Lab Sci; 1984; 14(3):179-88. PubMed ID: 6203466
[TBL] [Abstract][Full Text] [Related]
14. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
Ngan HY; Wong LC
Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two assays measuring human chorionic gonadotrophin serum concentrations in pregnancy termination and trophoblastic or non-trophoblastic tumours.
Wolff F; Gervy C; Gulbis B; Cotton F
Scand J Clin Lab Invest; 2017 Dec; 77(8):689-693. PubMed ID: 29069923
[TBL] [Abstract][Full Text] [Related]
16. HCG--choosing the best assay to monitor gestational trophoblastic disease and other germ cell tumours.
Evans BD; Harvey VJ; Knox BS; Duff G
N Z Med J; 1993 Jun; 106(958):261. PubMed ID: 8392672
[No Abstract] [Full Text] [Related]
17. Alpha-foetoprotein and carcinoembryonic antigen in germ cell neoplasms.
Talerman A; van der Pompe WB; Haije WG; Baggerman L; Boekestein-Tjahjadi HM
Br J Cancer; 1977 Mar; 35(3):288-91. PubMed ID: 66925
[TBL] [Abstract][Full Text] [Related]
18. Primary mediastinal trophoblastic teratomas.
Walden PA; Woods RL; Fox B; Bagshawe KD
Thorax; 1977 Dec; 32(6):752-8. PubMed ID: 74864
[TBL] [Abstract][Full Text] [Related]
19. Oral etoposide in gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Cancer Treat Rep; 1984 May; 68(5):775-7. PubMed ID: 6327035
[TBL] [Abstract][Full Text] [Related]
20. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
